Scott Burke, MD
Clinical Cardiac Electrophysiology · Newtown, PANPI 1164488987
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Boston Scientific at 57.6% of the total. Reporting peaked in 2019 at $6,892 and has fallen 81.1% since, to $1,302 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in PA, where the typical reported total is $15,643.
Across 328 payments — averaging $49.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Abbott$2K
- Biosense Webster, Inc.$2K
- Biotronik Inc.$1K
- Medtronic$567
- Johnson & Johnson$157
- plus $753 from 16 others
Across 6 payments — averaging $4471.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$16K
- Medical Device Business Services, Inc.$11K
What the payments were for
- Speaking & faculty fees$6,00037%
- Travel & lodging$2,09913%
- Food & beverage$8,15350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 90 | $9,356 |
| Abbott | 40 | $2,223 |
| Biosense Webster, Inc. | 102 | $1,982 |
| Biotronik Inc. | 27 | $1,214 |
| Medtronic(2 entities) | 12 | $567 |
| Johnson & Johnson | 11 | $157 |
| Pfizer | 10 | $135 |
| Amgen | 6 | $100 |
| Novartis | 5 | $71 |
| Kestra Medical Technology Services, Inc. | 2 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Philips North America LLC | 3 | $60 |
| Impulse Dynamics (USA) Inc. | 2 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Amarin Pharma, Inc. | 3 | $41 |
| Boehringer Ingelheim | 2 | $22 |
| Cardiva Medical, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Cook Medical LLC | 1 | $15 |
| Bayer | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$6,286
- Carto 3$1,058
- AVEIR$804
- COBALT DR MRI SURESCAN$164
- JOT DX$135
- WATCHMAN Access System$131
- OCTARAY MAPPING CATHETER$130
- Farapulse$125
- QDOT MICRO$121
- AZURE XT DR MRI SURESCAN$120
- GENERAL EP$108
- WATCHMAN FLX$104
- QDOT MICRO Catheter$101
How this compares
$16,252 in reported general payments places this provider in the 50th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 248 | $321,548 |
| XareltoRivaroxaban | 87 | $121,901 |
| MultaqDronedarone Hcl | 72 | $97,737 |
| Dofetilide | 126 | $22,364 |
| Propafenone Hcl ErPropafenone Hcl | 37 | $8,285 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 123 | $5,709 |
| Flecainide Acetate | 69 | $3,848 |
| Metoprolol Succinate | 191 | $2,792 |
| Amiodarone Hcl | 61 | $1,905 |
| Nadolol | 17 | $882 |
| SotalolSotalol Hcl | 24 | $590 |
| Digoxin | 23 | $587 |
| Carvedilol | 34 | $552 |
| Atorvastatin Calcium | 48 | $532 |
| Metoprolol Tartrate | 51 | $446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $135 | $321,548248 claims |
| Johnson & JohnsonXarelto | $157 | $121,90187 claims |
| Sanofi-aventis U.S. LLCMultaq | $62 | $97,73772 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Newtown
- Seth WorleyLancaster$3.7M
- John ChenaridesPittsburgh$750K
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pugazhendhi VijayaramanWilkes Barre$594K
- Pasquale SantangeliPhiladelphia$581K
- Joshua SilversteinPittsburgh$557K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
- Timothy MarkmanPhiladelphia$402K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.